血清甲状旁腺激素可预测接受冠状动脉造影的2型糖尿病患者的死亡率
研究纳入904例连续接受冠状动脉造影的白人患者(含235例2型糖尿病),平均随访6.3年。基线甲状旁腺激素(PTH)在有无2型糖尿病者间无显著差异(P=0.307);Cox回归显示PTH强烈预测2型糖尿病患者全因死亡(HR=2.35 [1.37-4.03];P=0.002),而在无2型糖尿病者中不预测(HR=1.04 [0.81-1.32];P=0.766),交互项P=0.006。校正糖化血红蛋白A1c、糖尿病病程、经典心血管危险因素、维生素D及肾功能后,PTH对2型糖尿病患者死亡风险的影响仍显著(HR=2.10 [1.10-4.10];P=0.030)。
要点
- 基线PTH在有无2型糖尿病者间无显著差异(P=0.307)。
- PTH预测2型糖尿病患者全因死亡(HR=2.35 [1.37-4.03];P=0.002)。
- PTH不预测无2型糖尿病者全因死亡(HR=1.04 [0.81-1.32];P=0.766)。
核心结论
- PTH对2型糖尿病患者全因死亡的预测作用显著强于无2型糖尿病者。
研究设计与样本
- 在904例连续接受冠状动脉造影评估确诊或疑似稳定冠心病的白人患者中测定血清PTH,其中235例合并2型糖尿病,前瞻性记录平均6.3年随访期间的死亡。
主要发现
- 基线PTH在有无2型糖尿病者间无显著差异(P=0.307)。
- Cox回归显示PTH强烈预测2型糖尿病患者全因死亡(HR=2.35 [1.37-4.03];P=0.002)。
- PTH不预测无2型糖尿病者全因死亡(HR=1.04 [0.81-1.32];P=0.766)。
- 交互项PTH×2型糖尿病显著(P=0.006),提示PTH对死亡风险的影响在2型糖尿病患者中显著更强。
- 校正糖化血红蛋白A1c、糖尿病病程、经典心血管危险因素、血清维生素D及肾功能后,PTH对2型糖尿病患者死亡风险的影响仍显著(HR=2.10 [1.10-4.10];P=0.030)。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Elevated serum levels of parathyroid hormone (PTH), one of the main regulators of calcium homeostasis and vitamin D metabolism, have been proposed as predictors of mortality. The impact of type 2 diabetes mellitus (T2DM) on the putative association between PTH and mortality has not been investigated thus far. AIM: The aim of our study was to investigate the impact of T2DM on the power of PTH to predict mortality risk. METHODS: Serum PTH levels were determined in 904 consecutive Caucasian patients referred to coronary angiography for the evaluation of established or suspected stable coronary artery disease (CAD), including 235 patients with T2DM. Prospectively, deaths were recorded over a mean follow-up period of 6.3 years. RESULTS: PTH at baseline did not differ significantly between patients with and without T2DM (P = .307). Cox regression analysis revealed that the serum PTH level strongly predicted all-cause mortality in patients with T2DM (hazard ratio [HR] = 2.35 [1.37-4.03]; P = .002), whereas PTH did not predict all-cause mortality in patients without T2DM (HR = 1.04 [0.81-1.32]; P = .766). The interaction term PTH × T2DM was significant (P = .006), indicating a significantly stronger impact of PTH on mortality risk in patients with T2DM than in individuals without diabetes. The impact of PTH on mortality risk in patients with T2DM remained significant after adjustment for glycated hemoglobin A1c, diabetes duration, classical cardiovascular risk factors, serum levels of vitamin D, and kidney function (HR = 2.10 [1.10-4.10]; P = .030). CONCLUSION: We conclude that PTH is a significantly stronger predictor of all-cause mortality in patients with T2DM than in those without T2DM.
引用
- Brandtner EM, Muendlein A, Leiherer A, et al. Serum Parathyroid Hormone Predicts Mortality in Coronary Angiography Patients with Type 2 Diabetes. J Clin Endocrinol Metab. 2020. PMID: 32785694. doi:10.1210/clinem/dgaa512
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。